JW Holdings Corporation

KSE 096760.KS

JW Holdings Corporation Shares (Diluted, Weighted) for the year ending December 31, 2023: 70,296,930

JW Holdings Corporation Shares (Diluted, Weighted) is 70,296,930 for the year ending December 31, 2023, a -2.72% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

JW Holdings Corporation Shares (Diluted, Weighted) for the year ending December 31, 2022 was 72,262,630, a 2.28% change year over year.
JW Holdings Corporation Shares (Diluted, Weighted) for the year ending December 31, 2021 was 70,653,257, a -1.52% change year over year.
JW Holdings Corporation Shares (Diluted, Weighted) for the year ending December 31, 2020 was 71,745,491, a -2.91% change year over year.
JW Holdings Corporation Shares (Diluted, Weighted) for the year ending December 31, 2019 was 73,899,298, a 4.00% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

KSE: 096760.KS

JW Holdings Corporation

CEO	Mr. Kyung-Ha Lee
IPO Date	May 5, 2006
Location	South Korea
Headquarters	2477, Nambusunhwan-ro
Employees	136
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Medical Instruments

Description

JW Holdings Corporation, together with its subsidiaries, manufactures and sells medicines and medical devices in South Korea and internationally. It offers ETC products, consumer healthcare OTC products, and IV solutions machinery systems. The company also exports its products. JW Holdings Corporation was founded in 1945 and is based in Seoul, South Korea.

Key trends

Past 5 years